Amol Deshpande
Founder and CEO @ Frontera Health
San Francisco Bay Area, United States
Amol Deshpande is a seed investor at Frontera Health in San Francisco Bay Area focused on Health Care and Software. Amol Deshpande is based out of Denver, Colorado and is the Founder and CEO of Frontera Health. Amol previously worked at Farmer's Business Network as a Co-Founder and Shareholder.Amol Deshpande attended the University of Illinois Urbana-Champaign.
- Total investments:
- 11
- Last investment:
- Lead investor:
- 18%
Last updated:
For AI agents: llms.txt
Industries Amol Deshpande invests in
Stages Amol Deshpande invests in
Countries Amol Deshpande invests in
Round sizes
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Round size
- Seed
- $1.5M–$4.3M
- Series A
- $15M–$16M
- Series B
- $6.3M–$22M
Investment Focus
Industry
- Health Care 3 (27%)
- Software 2 (18%)
- Renewable Energy 2 (18%)
- B2B 1 (9%)
- Sales 1 (9%)
Stage
- Seed 3 (27%)
- Series A 2 (18%)
- Series B 2 (18%)
- Series C 2 (18%)
- Funding Round 1 (9%)
Country
- United States 6 (55%)
- Israel 1 (9%)
- Norway 1 (9%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Greeneye Technology
|
Greeneye utilizes Artificial Intelligence to disrupt the agricultural pest control process, transitioning from the current practice of broadcast and wasteful spraying to precise and selective spraying of herbicides. Greeneye developed a proprietary selective spraying (SPP) system that turns every sprayer into a smart machine with seamlessintegration, Greeneye’s SSP system can detect weeds and spray them precisely in real-time, reducing up to 90% of herbicide usage. Demo - https://www.youtube.com/watch?v=iCOuTemX_cc&feature=youtu.beGreeneye is a leading technology company with a focus in precision agriculture, established in 2017 and based in Tel-Aviv, Israel. Greeneye has a multidisciplinary team with expertise in computer vision, artificial intelligence, agronomy, mechanical engineering, spraying applications, etc. We work with an extraordinary group of talented and visionary people who are committed to provide sustainable solutions for farmers around the world. | $20M / Venture - Series Unknown / Apr 17, 2024 | |
Linus Biotechnology
|
Linus Biotechnology develops a technology platform that builds on breakthroughs in exposome sequencing. The company was founded in 2020 by Manish Arora and is headquartered in New York, United States. | $16M / Series A / Jan 06, 2023 | |
Varos
|
Varos delivers the work of business analysts 10x faster, better, and cheaper using AI agents built for discovery.Most organizations rely on consultants, analysts, and countless meetings just to uncover knowledge their teams already have. Varos solves this by deploying AI agents that act as Senior Business Analysts—they talk to your teams throughbrief voice or text interviews, capture institutional knowledge, and analyze findings to deliver actionable insights.The information gathered is transformed into a secure, private knowledge base that organizations can use to assess current operations, capture business requirements, and share know-how across teams.In short, Varos helps companies uncover, understand, and use their own knowledge faster and more effectively | $4.3M / Seed / Feb 23, 2022 | |
Learnfully
|
Learnfully is a personalized online learning platform that provides recommendations and records progress toward goals. | $3M / Seed / Dec 08, 2021 | |
Opya
|
Opya is transforming autism care by successfully connecting treatment with technology. It is committed to the care and support of all individuals whose lives have been impacted by AutismThe company is a data-driven therapy platform designed to improve the effectiveness of the care we deliver. All being built to ensure families and clinicianshave the information they need to maximize their full potential. | $15.4M / Series A / Aug 18, 2021 | |
bttn
|
Wholesale medical supply platform | $1.5M / Seed / Jun 24, 2021 | |
Harvest Power
|
Harvest enables communities to produce renewable energy and high-value soil, mulch and organic fertilizer products from organic materials. The company harnesses the full potential of organic materials by recycling energy and nutrients back into local communities through its energy gardens and its production of nutrient-rich soils, mulches andfertilizers. Harvest owns and operates facilities throughout North America in British Columbia, Ontario, California and throughout the Mid-Atlantic, Midwest states and Northeastern US. | $110M / Series C / Apr 12, 2012 | |
Agilyx
|
We believe the time is right to expand advanced recycling, giving post-use plastic a new, circular life by converting this valuable material back into its original building blocks for reuse. By enabling plastic circularity on a global and commercial scale, we aim to play a vital role in accelerating the shift to a low-carbon economy. We haveco-founded Cyclyx International, Inc, a waste plastics management company, to work directly with industry participants to engineer customized plastic recovery programs that supply advanced and chemical recycling facilities. | $25M / Series C / Dec 19, 2011 | |
|
Harvest Power
|
Harvest enables communities to produce renewable energy and high-value soil, mulch and organic fertilizer products from organic materials. The company harnesses the full potential of organic materials by recycling energy and nutrients back into local communities through its energy gardens and its production of nutrient-rich soils, mulches andfertilizers. Harvest owns and operates facilities throughout North America in British Columbia, Ontario, California and throughout the Mid-Atlantic, Midwest states and Northeastern US. | $6.3M / Series B / May 24, 2011 | |
|
Agilyx
|
We believe the time is right to expand advanced recycling, giving post-use plastic a new, circular life by converting this valuable material back into its original building blocks for reuse. By enabling plastic circularity on a global and commercial scale, we aim to play a vital role in accelerating the shift to a low-carbon economy. We haveco-founded Cyclyx International, Inc, a waste plastics management company, to work directly with industry participants to engineer customized plastic recovery programs that supply advanced and chemical recycling facilities. | $22M / Series B / Mar 31, 2011 | |
| See all 11 investments → | |||
Co-Investors
About Frontera Health
Frontera Health is changing autism care in underprivileged regions with AI-powered tools that assist physicians in evaluating and treating children with autism and related diseases.
Frontera Health Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Amol Deshpande
Founder and CEO
|
|||
Bilal Zuberi
Member Board of Directors
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Amol Deshpande invest in?
Amol Deshpande invests primarily in Health Care, Software and Renewable Energy startups, most often at Seed and Series A stage. Most of the 11 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Amol Deshpande's check size?
Amol Deshpande typically joins rounds of $1.5M–$4.3M at Seed, $15M–$16M at Series A and $6.3M–$22M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Amol Deshpande participates in.
How do I contact Amol Deshpande?
Public channels for Amol Deshpande include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Amol Deshpande last invest?
The most recent investment recorded for Amol Deshpande closed in Apr 2024. Shizune tracks 11 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
